Insulin deal faces criticism over lack of insulin pens

Original Article by Christina Pitt | Bhekisisa Centre for Health Journalism | 16 August 2025

Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA's public hospitals.

Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA’s public hospitals.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Dis-Chem succession enters a new phase

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Read more...

Ectopic pregnancy deaths expose care gaps

Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.

Read more...

Childhood immunisation coverage falls sharply in SA

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.

Read more...